-
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice [Elektronski vir]Nysom Christiansen, Sara ...Objectives: In patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) initiating secukinumab, we aimed to assess and compare the proportion of patients achieving 6-, 12- and ... 24-month patient-reported outcomes (PRO) remission and the 24-month retention rates. Patients and methods: Patients with axSpA or PsA from 16 European registries, who initiated secukinumab in routine care were included. PRO remission rates were defined as pain, fatigue, Patient Global Assessment (PGA) ≤2 (Numeric Rating Scale (NRS) 0-10) and Health Assessment Questionnaire (HAQ) ≤0.5, for both axSpA and PsA, and were calculated as crude values and adjusted for drug adherence (LUNDEX). Comparisons of axSpA and PsA remission rates were performed using logistic regression analyses (unadjusted and adjusted for multiple confounders). Kaplan-Meier plots with log-rank test and Cox regression analyses were conducted to assess and compare secukinumab retention rates. Results: We included 3087 axSpA and 3246 PsA patients initiating secukinumab. Crude pain, fatigue, PGA and HAQ remission rates were higher in axSpA than in PsA patients, whereas LUNDEX-adjusted remission rates were similar. No differences were found between the patient groups after adjustment for confounders. The 24-month retention rates were similar in axSpA vs. PsA in fully adjusted analyses (HR [95 %CI] = 0.92 [0.84-1.02]). Conclusion: In this large European real-world study of axSpA and PsA patients treated with secukinumab, we demonstrate for the first time a comparable effectiveness in PRO remission and treatment retention rates between these two conditions when adjusted for confounders.Source: Seminars in arthritis and rheumatism. - ISSN 1532-866X (Vol. 65, iss. [article no.] 152388, 2024, str. 1-10)Type of material - e-article ; adult, seriousPublish date - 2024Language - englishCOBISS.SI-ID - 185698051
Author
Nysom Christiansen, Sara |
Horskjær Rasmussen, Simon |
Pons, Marion |
Michelsen, Brigitte |
Glintborg, Bente |
Gudbjornsson, Bjorn |
Grondal, Gerdur |
Vencovský, Jiří |
Rotar, Žiga |
Perdan-Pirkmajer, Katja
Topics
biologic therapy |
clinical study in epidemiology |
cohort study |
rheumatic diseases |
spondyloarthritis |
biološko zdravljenje |
klinična študija v epidemiologiji |
kohortna študija |
revmatske bolezni |
spondilartroza
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Nysom Christiansen, Sara | ![]() |
Horskjær Rasmussen, Simon | ![]() |
Pons, Marion | ![]() |
Michelsen, Brigitte | ![]() |
Glintborg, Bente | ![]() |
Gudbjornsson, Bjorn | ![]() |
Grondal, Gerdur | ![]() |
Vencovský, Jiří | ![]() |
Rotar, Žiga | 30545 |
Perdan-Pirkmajer, Katja | 29467 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.